Intimal deposition of functional von Willebrand factor in atherogenesis.
暂无分享,去创建一个
G. D. De Meyer | M. Hoylaerts | A. Herman | H. Yamamoto | M. Kockx | H. Bult | Marc F. Hoylaerts | A. G. Herman | Guido R. Y. De Meyer | Hiroshi Yamamoto
[1] P. Mannucci,et al. von Willebrand factor: a marker of endothelial damage? , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[2] G. D. De Meyer,et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. , 1998, Circulation research.
[3] E. Vicaut,et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. , 1998, Circulation.
[4] K. Kugiyama,et al. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[5] D. Bellinger,et al. von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[6] M. Lewis,et al. Redistribution of von Willebrand factor in porcine carotid arteries after balloon angioplasty. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[7] P. V. Van Schil,et al. Possible mechanisms of collar-induced intimal thickening. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[8] G. Remuzzi,et al. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. , 1997, Blood.
[9] A. Blann,et al. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. , 1997, Atherosclerosis.
[10] G. Lip,et al. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? , 1997, Cardiovascular research.
[11] M. Condorelli,et al. Inhibition of Leucocyte and Platelet Adhesion Reduces Neointimal Hyperplasia after Arterial Injury , 1997, Thrombosis and Haemostasis.
[12] C. Vrints,et al. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[13] J. Lin,et al. Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. , 1996, Atherosclerosis.
[14] E. Lesaffre,et al. Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure , 1996, Thrombosis and Haemostasis.
[15] S. Santavirta,et al. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. , 1996, The Journal of rheumatology.
[16] R. Knuechel,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.
[17] C. Ferran,et al. Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation , 1995 .
[18] J. Sixma,et al. Increased platelet deposition on atherosclerotic coronary arteries. , 1994, The Journal of clinical investigation.
[19] G. D. De Meyer,et al. The endothelium during cuff-induced neointima formation in the rabbit carotid artery. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[20] A. Federici,et al. Autopsy Findings in Three Patients with von Willebrand Disease Type IIB and Type III: Presence of Atherosclerotic Lesions without Occlusive Arterial Thrombi , 1993, Thrombosis and Haemostasis.
[21] V. Fuster,et al. von Willebrand Factor and Cardiovascular Disease , 1993, Thrombosis and Haemostasis.
[22] J. V. van Mourik,et al. Monocytes enhance endothelial von Willebrand factor release and prostacyclin production with different kinetics and dependency on intercellular contact between these two cell types , 1992, British journal of haematology.
[23] D. Warshaw,et al. Nucleotide sequences of the rabbit α-smooth-muscle and β-non-muscle actin mRNAs ☆ , 1992 .
[24] K. Bürrig,et al. The endothelium of advanced arteriosclerotic plaques in humans. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[25] D. Bellinger,et al. Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs. , 1991, Circulation.
[26] R. M. Lee,et al. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1990, Atherosclerosis.
[27] D. Tate,et al. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. , 1990, Arteriosclerosis.
[28] P. Isaacson. Ultrastructural Pathology of the Cell and Matrix: a Text and Atlas of Physiological and Pathological Alterations in the Fine Structure of Cellular and Extracellular Components , 1989 .
[29] S. Schwartz,et al. Injury induces increase of von Willebrand factor in rat endothelial cells. , 1989, The American journal of pathology.
[30] F. N. Ghadially. Ultrastructural pathology of the cell and matrix , 1988 .
[31] J. Sixma,et al. Interleukin‐l Inhibits the Synthesis of von Willebrand Factor in Endothelial Cells, Which Results in a Decreased Reactivity of Their Matrix toward Platelets , 1987, Arteriosclerosis.
[32] A. Schorer,et al. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells , 1987, British journal of haematology.
[33] J. Giddings,et al. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. , 1987, Thrombosis research.
[34] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[35] D. Wagner,et al. Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.
[36] L. Badimón,et al. The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells. , 1984, Atherosclerosis.
[37] P. D. de Groot,et al. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. , 1983, Biochimica et biophysica acta.
[38] J. Rand,et al. Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells. , 1982, The Journal of laboratory and clinical medicine.
[39] V. Fuster,et al. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. , 1978, The Journal of clinical investigation.
[40] J. Vermylen,et al. Antagonism of vWF Inhibits both Injury Induced Arterial and Venous Thrombosis in the Hamster , 1998, Thrombosis and Haemostasis.
[41] C. Ferran,et al. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. , 1995, Biochemical and biophysical research communications.
[42] P. Libby,et al. Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque , 1995, Journal of cardiovascular pharmacology.
[43] D. Wagner. Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.
[44] S. Breit,et al. Modulation of endothelial cell synthesis of von Willebrand factor by mononuclear cell products. , 1988, Haemostasis.
[45] F. N. Ghadially. Rod-shaped microtubulated bodies , 1988 .